MGMT promoter methylation in glioblastoma

被引:0
作者
Santosh, Vani [1 ]
Sravya, P. [2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bangalore, Karnataka, India
关键词
PHASE-3; TRIAL; TEMOZOLOMIDE; RADIOTHERAPY; CHEMOTHERAPY;
D O I
10.4103/0028-3886.236995
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:1115 / 1116
页数:2
相关论文
共 12 条
[1]   MGMT gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas [J].
Arora, Iteeka ;
Gurav, Mamta ;
Rumde, Rachna ;
Dhanavade, Sandeep ;
Kadam, Vinayak ;
Kurani, Hetakshi ;
Shetty, Omshree ;
Goda, Jayant Sastri ;
Shetty, Prakash ;
Moiyadi, Aliasgar ;
Gupta, Tejpal ;
Jalali, Rakesh ;
Epari, Sridhar .
NEUROLOGY INDIA, 2018, 66 (04) :1106-1114
[2]   The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials [J].
Binabaj, Maryam Moradi ;
Bahrami, Afsane ;
ShahidSales, Soodabeh ;
Joodi, Marjan ;
Mashhad, Mona Joudi ;
Hassanian, Seyed Mahdi ;
Anvari, Kazem ;
Avan, Amir .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) :378-386
[3]  
DAlessandris QG, 2014, J CANC SCI THER, V6, P136
[4]   MGMT gene silencing and benefit from temozolomide in glioblastoma [J].
Hegi, ME ;
Diserens, A ;
Gorlia, T ;
Hamou, M ;
de Tribolet, N ;
Weller, M ;
Kros, JM ;
Hainfellner, JA ;
Mason, W ;
Mariani, L ;
Bromberg, JEC ;
Hau, P ;
Mirimanoff, RO ;
Cairncross, JG ;
Janzer, RC ;
Stupp, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003
[5]   Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial [J].
Malmstrom, Annika ;
Gronberg, Bjorn Henning ;
Marosi, Christine ;
Stupp, Roger ;
Frappaz, Didier ;
Schultz, Henrik ;
Abacioglu, Ufuk ;
Tavelin, Bjorn ;
Lhermitte, Benoit ;
Hegi, Monika E. ;
Rosell, Johan ;
Henriksson, Roger .
LANCET ONCOLOGY, 2012, 13 (09) :916-926
[6]   Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma [J].
Perry, James R. ;
Laperriere, Normand ;
O'Callaghan, Christopher J. ;
Brandes, Alba A. ;
Menten, Johan ;
Phillips, Claire ;
Fay, Michael ;
Nishikawa, Ryo ;
Cairncross, J. Gregory ;
Roa, Wilson ;
Osoba, David ;
Rossiter, John P. ;
Sahgal, Arjun ;
Hirte, Hal ;
Laigle-Donadey, Florence ;
Franceschi, Enrico ;
Chinot, Olivier ;
Golfinopoulos, Vassilis ;
Fariselli, Laura ;
Wick, Antje ;
Feuvret, Loic ;
Back, Michael ;
Tills, Michael ;
Winch, Chad ;
Baumert, Brigitta G. ;
Wick, Wolfgang ;
Ding, Keyue ;
Mason, Warren P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1027-1037
[7]   MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma [J].
Rivera, Andreana L. ;
Pelloski, Christopher E. ;
Gilbert, Mark R. ;
Colman, Howard ;
De La Cruz, Clarissa ;
Sulman, Erik P. ;
Bekele, B. Nebiyou ;
Aldape, Kenneth D. .
NEURO-ONCOLOGY, 2010, 12 (02) :116-121
[8]   MGMT methylation in glioblastoma: tale of the tail [J].
Shah, Nameeta ;
Schroeder, Brett ;
Cobbs, Charles .
NEURO-ONCOLOGY, 2015, 17 (01) :167-168
[9]   MGMT Promoter Methylation Correlates with an Overall Survival Benefit in Chinese High-Grade Glioblastoma Patients Treated with Radiotherapy and Alkylating Agent-Based Chemotherapy: A Single-Institution Study [J].
Shen, Dong ;
Liu, Tao ;
Lin, Qingfen ;
Lu, Xiangdong ;
Wang, Qiong ;
Lin, Feng ;
Mao, Weidong .
PLOS ONE, 2014, 9 (09)
[10]   Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial [J].
Stupp, Roger ;
Hegi, Monika E. ;
Mason, Warren P. ;
van den Bent, Martin J. ;
Taphoorn, Martin J. B. ;
Janzer, Robert C. ;
Ludwin, Samuel K. ;
Allgeier, Anouk ;
Fisher, Barbara ;
Belanger, Karl ;
Hau, Peter ;
Brandes, Alba A. ;
Gijtenbeek, Johanna ;
Marosi, Christine ;
Vecht, Charles J. ;
Mokhtari, Karima ;
Wesseling, Pieter ;
Villa, Salvador ;
Eisenhauer, Elizabeth ;
Gorlia, Thierry ;
Weller, Michael ;
Lacombe, Denis ;
Cairncross, J. Gregory ;
Mirimanoff, Rene-Olivier .
LANCET ONCOLOGY, 2009, 10 (05) :459-466